STATE OF WISCONSIN INVESTMENT BOARD - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$313,325
-66.1%
79,524
-8.5%
0.00%
-66.7%
Q2 2023$923,439
+62.6%
86,871
+27.4%
0.00%
+50.0%
Q1 2023$568,064
+38.8%
68,195
+53.8%
0.00%
+100.0%
Q4 2022$409,304
+108.8%
44,345
+191.2%
0.00%0.0%
Q3 2022$196,000
+4.3%
15,230
+6.8%
0.00%
Q2 2022$188,000
-77.7%
14,259
-64.4%
0.00%
-100.0%
Q1 2022$842,000
+102.9%
40,000
+131.2%
0.00%
+100.0%
Q4 2021$415,000
-5.7%
17,3000.0%0.00%0.0%
Q3 2021$440,000
-24.4%
17,3000.0%0.00%0.0%
Q2 2021$582,000
-13.4%
17,3000.0%0.00%0.0%
Q1 2021$672,000
-37.3%
17,3000.0%0.00%
-50.0%
Q4 2020$1,071,000
+64.0%
17,300
-11.3%
0.00%0.0%
Q3 2020$653,000
+40.4%
19,5000.0%0.00%
+100.0%
Q2 2020$465,000
+44.0%
19,500
+38.3%
0.00%0.0%
Q1 2020$323,000
-18.0%
14,100
+1.4%
0.00%0.0%
Q4 2019$394,000
+31.8%
13,9000.0%0.00%0.0%
Q3 2019$299,00013,9000.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 296,822$7,551,0001.86%
RTW INVESTMENTS, LP 3,644,248$92,710,0001.40%
Cormorant Asset Management, LP 1,278,276$32,519,0001.32%
Redmile Group, LLC 2,381,958$60,597,0001.06%
HighVista Strategies LLC 47,594$1,211,0000.80%
Birchview Capital, LP 15,000$382,0000.26%
GILDER GAGNON HOWE & CO LLC 1,123,355$28,578,0000.15%
Artal Group S.A. 250,000$6,360,0000.14%
Tekla Capital Management LLC 99,263$2,525,0000.08%
Casdin Capital, LLC 120,000$3,053,0000.08%
View complete list of STOKE THERAPEUTICS INC shareholders